Potocki-Lupski syndrome (PTLS) is a rare genetic disorder associated with neurodevelopmental delay and heart defects. We report the first case of prenatal diagnosis of PTLS in a fetus with hypoplastic left heart and aberrant right subclavian artery. Detection of a fetal heart defect should be followed by chromosomal and genetic studies in order to rule out fetal aneuploidy and/or associated genetic syndromes with significant implications for the treatment of children with PTLS.
Introduction
Potocki-Lupski syndrome (PTLS) (OMIM no. 610883) is a recently described genetic disorder associated with duplication 17p11.2. 1 The incidence of PTLS is thought to be at least 1 in 20 000 individuals, although fewer than 50 cases have been described in the medical literature. 2 PTLS is associated with neurodevelopmental and behavioral disorders and congenital heart defects (CHDs). 1, 2 Improvements in ultrasound equipment, systematic use of fetal echocardiographic protocols and the emergence of new ultrasound markers such as detection of aberrant right subclavian artery (ARSA) mean that CHDs are increasingly reported. 3 Prenatal detection of CHDs by ultrasound scan should be followed by additional investigations in order to rule out other frequently associated anatomical, chromosomal or genetic disorders. 3 In this sense, screening for genetic syndromes associated with pediatric CHDs (for example, PTLS) should form part of prenatal care.
We report a case of prenatal diagnosis of PTLS after chromosomal studies that were undertaken because of a fetal heart malformation.
Case
A 39-year-old woman in her 26th week of gestation was evaluated in our Fetal Medicine Unit because of suspected fetal heart malformation. Transabdominal ultrasound scan (4 to 8 MHz, GE Logic 9 Voluson Expert) revealed a hypoplastic left ventricle, mitral-aortic atresia and ARSA with no other pathological findings. Figure 1 shows a transverse view of the fetal thorax with dilation of the pulmonary artery and ductal arch, filiform aortic arch and ARSA. After consultation with a geneticist, the parents agreed to determination of fetal karyotype by amniocentesis. Genetic studies by fluorescence in situ hybridization, G-banded chromosome analysis and array comparative genomic hybridization revealed PTLS with karyotype 46XY þ 17p11.2. The impact of PLS and hypoplastic left ventricle was discussed with the parents, who rejected termination of pregnancy, despite the poor prognosis. The pregnancy was unremarkable. Delivery was at 39 weeks of gestation, and the newborn (weight 3240 g) was admitted to the neonatal intensive care unit. Postnatal evaluation did not reveal any further abnormalities. Both a pediatric surgeon and a cardiac surgeon discussed with the parents the treatment alternatives and they decided to perform a Norwood surgery with a Sano shunt rather than no surgery; however, the infant died of heart failure after the first intervention (day 16 postpartum).
Discussion
We report the case of a fetus with hypoplastic left heart and ARSA in which chromosomal studies revealed PTLS.
PTLS was first reported in 1996, although the first detailed study did not appear until 2007.
1 Associated with duplication 17p11.2, PTLS is the first predictable reciprocal microduplication syndrome described, 1 and the reciprocal homologous recombination of the Smith-Magenis syndrome (microdeletion 17p11.2) (OMIM #610883). Both syndromes are associated with major congenital malformation and neurodevelopmental and behavioral disorders. 1 studied a large population in a multidisciplinary clinical trial. These authors found a >50% prevalence of structural cardiovascular conditions, including atrial septal defects with left-to-right shunting, dilated aortic root and bicuspid aortic valve. However, recently, Sanchez-Valle et al. 5 and Yusupov et al. 6 reported two cases of children with PTLS and hypoplastic left heart syndrome (HLHS). To our knowledge, we present the first case of PTLS after prenatal diagnosis of a CHD (specifically, HLHS and ARSA).
CHD detected by ultrasound scan should be followed by further investigations to rule out other major malformations and chromosomal or genetic disorders. This is particularly true of selected types of CHD such as conotruncal defects with thymic hypoplasia, which are associated with chromosome 22 microdeletions, and pulmonary valvular stenosis and tetralogy of Fallot, which are associated with JAG1 gene mutations in Alagille syndrome. [7] [8] [9] Other genetic disorders could also be associated with a specific cardiac phenotype. 10 Therefore, prenatal screening for genetic disorders in certain types of CHDs should be undertaken, so that a more accurate prognosis can be offered to parents, who might consider therapeutic alternatives such as compassionate care or withholding cardiac surgery.
Fluorescence in situ hybridization and G-banded chromosome analysis are the first step in ruling out chromosomal aberrations and genetic disorders; in cases of suspected PTLS, array comparative genomic hybridization would be appropriate.
The correlation between chromosomal and genetic abnormalities (for example, trisomy, duplication, deletion and mutation) and cardiac anatomical patterns suggests that specific morphogenetic mechanisms set in motion by genes can result in a specific cardiac phenotype. 1, 4 In the case of PTLS, the mechanisms responsible for the cardiovascular defects are unknown, as 17p11.2 is not among the regions previously associated with HLHS, left ventricle outflow tract (LVOT) defects, or ARSA. More in-depth clinical investigation will be necessary to determine whether LVOT defects and HLHS represent a considerable proportion of the CHDs most frequently found in PTLS.
In our case, early diagnosis of PTLS facilitated better counseling to parents, with respect to the implications of a severe heart malformation such as HLHS. Most children with HLHS have surgery during the first days of life in order to survive, and several options are available (Norwood procedure with a Sano shunt, Glenn procedure, Fontan procedure). However, chronic health problems and severe complicationsFeven heart failureFcan persist, and the patient may have to undergo a heart transplant. 11 As these operations are complex, a cardiologist must assess all medical, compassionate and surgical options on a case-by-case basis. A study in 2003 showed that a selection of experts in the care of children with HLHS were evenly split when asked what they would do if their own children were born with HLHS: one-third stated that they would choose surgery, one-third stated that they would choose palliative (compassionate) treatment without surgery and one-third stated that they were uncertain which choice they would make. 12 However, studies show that when parents are presented with the available options, half choose life-prolonging interventions and half choose compassionate care. 12, 13 Therefore, large multicentric trials and registries are necessary to improve care.
As PTLS is associated with neurological disabilities, it may be difficult to discern in a newborn with severe CHD and could be attributed to complications of CHD itself. In addition, given the poor outcome in patients with these conditions, the implications of a severe congenital heart malformation in the context of a genetic syndrome should be taken into account when considering surgical repair. 14 
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